2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thrombocythemia, Essential
1
Recurrence
1
Primary Myelofibrosis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Interventions
Specimen Handling
640
pembrolizumab
570
Magnetic Resonance Spectroscopy
550
Carboplatin
430
Cyclophosphamide
382
Cisplatin
376
Biopsy
364
Paclitaxel
312
Nivolumab
310
Gemcitabine
302
Radiotherapy
275
Bevacizumab
243
Dexamethasone
213
fludarabine
209
Docetaxel
193
durvalumab
182
atezolizumab
179
Oxaliplatin
173
Rituximab
168
Fluorouracil
168
venetoclax
167
Pemetrexed
165
Doxorubicin
163
Radiation
161
Capecitabine
161
Radiosurgery
149
Etoposide
138
Ipilimumab
136
Leucovorin
134
Lenalidomide
133
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INCB057643
×
90 days
×
Clear all
NCT04279847
2026-04-01
LIMBER
Incyte Corporation
Phase 1
Active not recruiting
140 enrolled